| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, Prisma Group PLoS med 6 (7), e1000097, 2009 | 81552* | 2009 |
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration A Liberati, DG Altman, J Tetzlaff, C Mulrow, PC Gøtzsche, JPA Ioannidis, ... Journal of clinical epidemiology 62 (10), e1-e34, 2009 | 24394 | 2009 |
| Meta-analysis of observational studies in epidemiology: a proposal for reporting DF Stroup, JA Berlin, SC Morton, I Olkin, GD Williamson, D Rennie, ... Jama 283 (15), 2008-2012, 2000 | 13882 | 2000 |
| The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials JPT Higgins, DG Altman, PC Gøtzsche, P Jüni, D Moher, AD Oxman, ... Bmj 343, d5928, 2011 | 12307 | 2011 |
| The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials D Moher, KF Schulz, D Altman, Consort Group Jama 285 (15), 1987-1991, 2001 | 9068* | 2001 |
| Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement D Moher, L Shamseer, M Clarke, D Ghersi, A Liberati, M Petticrew, ... Systematic reviews 4 (1), 1, 2015 | 6413 | 2015 |
| Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement D Moher, DJ Cook, S Eastwood, I Olkin, D Rennie, DF Stroup Oncology Research and Treatment 23 (6), 597-602, 2000 | 5187 | 2000 |
| The revised CONSORT statement for reporting randomized trials: explanation and elaboration DG Altman, KF Schulz, D Moher, M Egger, F Davidoff, D Elbourne, ... Annals of internal medicine 134 (8), 663-694, 2001 | 4109 | 2001 |
| Improving the quality of reporting of randomized controlled trials: the CONSORT statement C Begg, M Cho, S Eastwood, R Horton, D Moher, I Olkin, R Pitkin, ... Jama 276 (8), 637-639, 1996 | 4030 | 1996 |
| Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation L Shamseer, D Moher, M Clarke, D Ghersi, A Liberati, M Petticrew, ... Bmj 349, 2015 | 3911 | 2015 |
| Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative PM Bossuyt, JB Reitsma, DE Bruns, CA Gatsonis, PP Glasziou, LM Irwig, ... Radiology 226 (1), 24-28, 2003 | 3887 | 2003 |
| Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews BJ Shea, JM Grimshaw, GA Wells, M Boers, N Andersson, C Hamel, ... BMC medical research methodology 7 (1), 10, 2007 | 3722 | 2007 |
| Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? D Moher, A Jones, DJ Cook, AR Jadad, M Moher, P Tugwell, TP Klassen The Lancet 352 (9128), 609-613, 1998 | 3199 | 1998 |
| CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials KF Schulz, DG Altman, D Moher Annals of internal medicine 152 (11), 726-732, 2010 | 2781 | 2010 |
| Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ... Bmj 348, 2014 | 2772 | 2014 |
| Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials JAC Sterne, AJ Sutton, JPA Ioannidis, N Terrin, DR Jones, J Lau, ... Bmj 343, 2011 | 2640 | 2011 |
| Cochrane handbook for systematic reviews of interventions Cochrane Collaboration Cochrane Collaboration, 2008 | 2372* | 2008 |
| The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration PM Bossuyt, JB Reitsma, DE Bruns, CA Gatsonis, PP Glasziou, LM Irwig, ... Annals of internal medicine 138 (1), W1-12, 2003 | 2355 | 2003 |
| SPIRIT 2013 statement: defining standard protocol items for clinical trials AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ... Annals of internal medicine 158 (3), 200-207, 2013 | 2119 | 2013 |
| Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration I Boutron, D Moher, DG Altman, KF Schulz, P Ravaud Annals of internal medicine 148 (4), 295-309, 2008 | 1963 | 2008 |
